Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00208260 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intensified Chemotherapy in CRC After Resection of Liver Metastases

StatusCompleted
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study Status, Referencesv4
  2. Re-verified, no change to tracked fieldsv3
  3. Enrollment target: 300 to 124 Trial status: Recruiting to Completed · Completion date: Aug 2007 · Interventions: 5FU/AF (Drug), Irinotecan (Drug), Oxaliplatin (Drug) to FOLFIRI (Drug), FOLFIRI-HD (Drug), FOLFIRINOX (Drug), FOLFOX-4 (Drug), FOLFOX-7 (Drug) · 4 morev2 Show all 8 changesShow less
    • Trial status: Recruiting to Completed
    • Completion date: Aug 2007
    • Interventions: 5FU/AF (Drug), Irinotecan (Drug), Oxaliplatin (Drug) to FOLFIRI (Drug), FOLFIRI-HD (Drug), FOLFIRINOX (Drug), FOLFOX-4 (Drug), FOLFOX-7 (Drug)
    • Secondary endpoints: 2 to 3
    • Site details revised
    • Collaborators: 1 to 3
    • Study arms: 0 to 5

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.
Trial Details
NCT Number NCT00208260
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators: Pfizer, Sanofi, Chugai Pharmaceutical
Conditions Colorectal Cancer, Liver Metastases, Chemotherapy
Enrollment 124 participants
Start Date
Study Completion (estimated)
Updated on ClinicalTrials.gov